Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AREV Life Sciences Global Corp C.AREV

Alternate Symbol(s):  AREVF

AREV Life Sciences Global Corp. is a Canada-based biotechnology company engaged in the discovery and commercialization of solutions for health and wellness. It produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well... see more

CSE:AREV - Post Discussion

AREV Life Sciences Global Corp > AREV extractions towards beating COVID 19
View:
Post by Alexandchoy on Feb 17, 2021 2:10pm

AREV extractions towards beating COVID 19

AREV is pursuing collaborations with a number of world renowned University centers to facilitate advanced extraction of potential antiviral phytochemicals from medicinal plants that may be used to develop drugs against COVID-19. Dipping down to $0.36 and looking like a buy IMO

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities